An article by Pyrodex Testing founder and principal Djik Maouyo was published in January by the PDA Letter, the magazine of the Parenteral Drug Association.
Read MorePyrodex is a proud member of the Lifebridge Health BioIncubator at Sinai Hospital - Maryland's only hospital-based bioincubator.
Read More“These minority-founded businesses represent the audacious ideas that make Maryland such a thriving technology ecosystem,” said George Davis, CEO of TEDCO. “MBPF is competitive, and only the best ideas supported by a thoughtful commercialization plan receive an investment – these awardees are among the best of the best.”
Read MorePopular endotoxin detection kits based on the horseshoe crab blood cell lysates fail to address the detrimental impact of non-endotoxin pyrogens or fever-causing substances on the effects of parenteral medical drugs in their different phases of clinical applications. However, new detection methods can identify all pyrogenic contaminants in injectable medicines and implantable medical devices, and help reduce or eliminate the risk of fever, septic shock, organ failure or death associated with the administration of new drugs or compounds.
Read MorePyrogen (fever-causing) contaminant testing is a process fraught with challenges. Since commonly-used tests based on animal products are hampered by delayed results, incomplete scope and false negatives, many medical devices, and drug makers are searching for better, more efficient options.
Read More